US2021364538A1PendingUtilityA1

Diagnostic and treatment assembly

Assignee: RADIOLIFE COPriority: May 22, 2020Filed: Jun 11, 2021Published: Nov 25, 2021
Est. expiryMay 22, 2040(~13.8 yrs left)· nominal 20-yr term from priority
G01N 22/00G01N 35/00732B01L 2300/024B01L 3/545G01N 2035/00851G01N 2035/00782B01L 2300/022G01N 33/487
52
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A diagnostic and treatment assembly, configured to diagnose and treat cellular disease. The diagnostic and treatment assembly has a radio wave generator communicatively coupled to a carrier modulator and a radio wave amplifier. An impedance matching system is electrically coupled to the radio wave amplifier. A reflected wave sensor is electrically coupled to the impedance matching system. A radiator applicator is electrically coupled to the reflected wave sensor. A vector impedance analyzer is electrically coupled to the radio wave amplifier. An information collector data network is electrically coupled to the vector impedance analyzer. A data logger is communicatively coupled to the carrier modulator, the vector impedance analyzer, and the reflected wave sensor. The diagnostic and treatment assembly operates in a low-power mode to diagnose a cellular disease and in a high-power mode to treat the cellular disease.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A method of analyzing a suspected biological sample to determine the frequency to identify a virus in said suspected biological sample comprising of:
 a. collecting a reference biological sample that does not have the virus and placing it in a first container;   b. collecting said suspected biological sample and placing said suspected biological sample in a second container;   c. exposing said reference biological sample in said first container to radio waves;   d. said radio waves having a radio wave frequency;   e. exposing said suspected biological sample in said second container to radio wave frequency;   f. measuring the energy absorption of said radio wave frequency of said suspected biological sample in said second container;   g. measuring the phase of said reference biological sample in said first container;   h. measuring the magnetic reluctance of said reference biological sample in said first container;   i. using said radio wave frequency of said suspected biological sample in said second container and said phase of said reference biological sample and said magnetic reluctance of said reference biological sample in said first container; and   j. determining the fundamental frequency.   
     
     
         2 . The method of analyzing said suspected biological sample of  claim 1  wherein the virus is selected from the group consisting of Influenza, Coronavirus, Sars-Cov-2, HIV, Herpes, Dengue and Zika. 
     
     
         3 . The method of analyzing said suspected biological sample of  claim 1  wherein said radio waves frequency is selected from the group consisting of 1500 Terahertz (THz) to 150 THz. 
     
     
         4 . The method of analyzing said suspected biological sample of  claim 1  wherein said radio waves frequency is preferably 920 THz. 
     
     
         5 . The method of analyzing said suspected biological sample of  claim 1  wherein said radio waves frequency is a fundamental frequency to resonate with the structure. 
     
     
         6 . The method of analyzing said suspected biological sample of  claim 1  wherein said energy absorption of said reference biological sample in said container is a stored value.

Join the waitlist — get patent alerts

Track US2021364538A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.